Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1551
Number of pages	1
Journal	The New England journal of medicine
Volume	394
Issue number	15
DOIs	https://doi.org/10.1056/NEJMc2600572
Publication status	Published - 16-Apr-2026

Access to Document

@article{a3be86730ef74fb58155ba5944289105,

title = "Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes",

author = "\{van Bruggen\}, Folkert",

year = "2026",

month = apr,

day = "16",

doi = "10.1056/NEJMc2600572",

language = "English",

volume = "394",

pages = "1551",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOC",

number = "15",

}

TY - JOUR

T1 - Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes

AU - van Bruggen, Folkert

PY - 2026/4/16

Y1 - 2026/4/16

UR - https://www.scopus.com/pages/publications/105035817920

U2 - 10.1056/NEJMc2600572

DO - 10.1056/NEJMc2600572

M3 - Comment/Letter to the editor

C2 - 41985144

AN - SCOPUS:105035817920

SN - 0028-4793

VL - 394

SP - 1551

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 15

ER -